Inhibition of Notch enhances efficacy of immune checkpoint blockade in triple-negative breast cancer
Science Advances · 2024-11 · 10 (44)
DOI: 10.1126/sciadv.ado8275 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Advances, 2024-11. Verfasst von Qiang Shen und 5 weiteren Autor:innen. Beteiligte Einrichtung: Ontario Cancer Institute, University Health Network, 610 University Avenue, Toronto, Ontario M5G 2M9, Canada. Hauptthemen laut MEDLINE: Triple Negative Breast Neoplasms, Immune Checkpoint Inhibitors, Tumor Microenvironment, Receptors, Notch. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 92 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Aberrant Notch, which is a defining feature of triple-negative breast cancer (TNBC) cells, regulates intercellular communication in the tumor immune microenvironment (TIME). This includes tumor-associated macrophage (TAM) recruitment through Notch-dependent cytokine secretion, contributing to an immunosuppressive TIME. Despite the low response rate of TNBC to immune checkpoint blockade (ICB), here, we report that inhibition of Notch-driven cytokine-mediated programs reduces TAMs and induces responsiveness to sequentially delivered ICB. This is characterized by the emergence of GrB + cytotoxic T lymphocytes (CTLs) in the primary tumor. A more impressive effect of sequential treatment is observed in the lung where TAM depletion and increased CTLs are accompanied by near-complete abolition of metastases. This is due to (i) therapeutic reduction in Notch-dependent, prometastatic circulating factors released by the primary tumor, and (ii) elevated PD ligand 1 (PD-L1) in lung metastases, rendering them profoundly sensitive to ICB. These findings highlight the potential of combination cytokine inhibition and ICB as an immunotherapeutic strategy in TNBC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Ontario Cancer Institute, University Health Network, 610 University Avenue, Toronto, Ontario M5G 2M9, Canada.
- Department of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.
- Department of Medicine, Division of Medical Oncology, University of Toronto, Toronto, Ontario, Canada.
- Department of Immunology, University of Toronto, Medical Sciences Building, 1 King's College Circle, Room 7205, Toronto, Ontario M5S 1A8, Canada.
- Department of Medical Biophysics, University of Toronto, Toronto Medical Discovery Tower, MaRS Centre, 101 College Street, Room 15-701, Toronto, Ontario M5G 2M9, Canada.
- Department of Surgical Oncology, Princess Margaret Cancer Centre, University Health Network, 610 University Avenue, Suite 8-411, Toronto, Ontario M5G 2M9, Canada.
ORCID-Profile: Qiang Shen, Kiichi Murakami, Marcus Butler, Pamela S Ohashi, Michael Reedijk
Zitieren
APA
Shen, Q., Murakami, K., Sotov, V., Butler, M., Ohashi, P. S., & Reedijk, M. (2024). Inhibition of Notch enhances efficacy of immune checkpoint blockade in triple-negative breast cancer. Science Advances, 10(44). https://doi.org/10.1126/sciadv.ado8275
Vancouver
Shen Q, Murakami K, Sotov V, Butler M, Ohashi PS, Reedijk M. Inhibition of Notch enhances efficacy of immune checkpoint blockade in triple-negative breast cancer. Science Advances. 2024;10(44). doi:10.1126/sciadv.ado8275
BibTeX
@article{Shen2024,
author = {Shen, Qiang and Murakami, Kiichi and Sotov, Valentin and Butler, Marcus and Ohashi, Pamela S and Reedijk, Michael},
title = {Inhibition of Notch enhances efficacy of immune checkpoint blockade in triple-negative breast cancer},
journal = {Science Advances},
year = {2024},
volume = {10},
number = {44},
doi = {10.1126/sciadv.ado8275}
}
EUVIMED